Telix Pharmaceuticals Ltd. (AU:TLX) has released an update.
Telix Pharmaceuticals Limited has seen the termination of lock-up agreements following their decision to withdraw from a planned initial public offering in the US, leading to the cessation of Joint Lead Managers as substantial holders. This move comes after the announcement made on June 14, 2024, marking a significant change in the company’s shareholding structure.
For further insights into AU:TLX stock, check out TipRanks’ Stock Analysis page.
